You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
31 October 2025 - Denmark-based vaccines company Bavarian Nordic A/S (CPH:BAVA) announced on Friday it has been awarded a new and expanded procurement framework contract by the European Commission through the Health Emergency Preparedness and Respons...
31 October 2025 - Swiss biopharmaceutical company Pilatus Biosciences announced on Thursday that new preclinical data for its lead product candidate, PLT012, will be presented at the upcoming Society for Immunotherapy of Cancer (SITC) 2025 Annual Mee...
30 October 2025 - Cellipont Bioservices, a cell therapy Contract Development and Manufacturing Organisation (CDMO), announced on Wednesday that it has partnered with Ernexa Therapeutics (Nasdaq:ERNA), a developer of novel cell therapies for the treat...
30 October 2025 - China-based global biotech company Shanghai Ark Biopharmaceutical Co Ltd (ArkBio) announced on Wednesday the start of a Phase II clinical study of AK0610, a fully human monoclonal antibody designed to prevent respiratory syncytial v...
29 October 2025 - Danish clinical-stage radiopharmaceuticals company Curasight A/S (Spotlight: CURAS) on Wednesday reported continued progress in its Phase 2 study of the diagnostic platform uTRACE in prostate cancer.All nine clinical sites in German...
29 October 2025 - Animal health business Zoetis Inc (NYSE: ZTS) announced on Wednesday that the European Commission has granted marketing authorization for Portela (relfovetmab), the first monoclonal antibody therapy with a three-month dosing interva...
29 October 2025 - Tandem Diabetes Care Inc (NASDAQ: TNDM) announced on Wednesday that it has launched the t:slim X2 insulin pump integrated with Abbott's FreeStyle Libre 3 Plus continuous glucose monitoring (CGM) sensor in the US, marking the st...